These studies, based on both cancer (PD-L1 and CTLA-4) and allergy (IL-5) associated self-antigen targets, demonstrated a consistent ability of the spy-VLP mediated antigen-display to facilitate induction of potent autoantibody responses. The gene discussed is IL5; the disease is allergic disease.